Term Name: EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
Synonyms: ATP:protein phosphotransferase (MAPKK-activated) inhibitor, ATP:protein phosphotransferase (MAPKK-activated) inhibitors, c-Jun N-terminal kinase inhibitor, c-Jun N-terminal kinase inhibitors, Dp38 inhibitor, Dp38 inhibitors, EC 2.7.11.24 (mitogen-activated protein kinase) inhibitors, EC 2.7.11.24 inhibitor, EC 2.7.11.24 inhibitors, ERK inhibitor, ERK inhibitors, ERK1 inhibitor, ERK1 inhibitors, ERK2 inhibitor, ERK2 inhibitors, extracellular signal-regulated kinase inhibitor, extracellular signal-regulated kinase inhibitors, JNK inhibitor, JNK inhibitors, JNK3alpha1 inhibitor, JNK3alpha1 inhibitors, LeMPK3 inhibitor, LeMPK3 inhibitors, MAP kinase inhibitor, MAP kinase inhibitors, MAP-2 kinase inhibitor, MAP-2 kinase inhibitors, MAPK inhibitor, MAPK inhibitors, MBP kinase I inhibitor, MBP kinase I inhibitors, MBP kinase II inhibitor, MBP kinase II inhibitors, MEK inhibitor, MEK inhibitors, microtubule-associated protein 2 kinase inhibitor, microtubule-associated protein 2 kinase inhibitors, microtubule-associated protein kinase inhibitor, microtubule-associated protein kinase inhibitors, mitogen-activated protein kinase (EC 2.7.11.24) inhibitor, mitogen-activated protein kinase (EC 2.7.11.24) inhibitors, mitogen-activated protein kinase inhibitor, mitogen-activated protein kinase inhibitors, myelin basic protein kinase inhibitor, myelin basic protein kinase inhibitors, p38-2 inhibitor, p38-2 inhibitors, p38delta inhibitor, p38delta inhibitors, p42 mitogen-activated protein kinase inhibitor, p42 mitogen-activated protein kinase inhibitors, p42(mapk) inhibitor, p42(mapk) inhibitors, p44mpk inhibitor, p44mpk inhibitors, PMK-1 inhibitor, PMK-1 inhibitors, PMK-2 inhibitor, PMK-2 inhibitors, PMK-3 inhibitor, PMK-3 inhibitors, pp42 inhibitor, pp42 inhibitors, pp44(mapk) inhibitor, pp44(mapk) inhibitors, SAPK inhibitor, SAPK inhibitors, STK26 inhibitor, STK26 inhibitors, stress-activated protein kinase inhibitor, stress-activated protein kinase inhibitors
Definition: An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of mitogen-activated protein kinase (EC 2.7.11.24).
Ontology: ChEBI [CHEBI:79091]  ( EBI )

Relationships
is a type of: EC 2.7.11.* (protein-serine/threonine kinase) inhibitor protein kinase inhibitor
has subtype: c-Jun N-terminal kinase inhibitor
inverse has_role: 1-(3-tert-butyl-1-methylpyrazol-5-yl)-3-(4-chlorophenyl)urea 2-(2-amino-3-methoxyphenyl)chromen-4-one 3-fluoro-5-morpholin-4-yl-N-[1-(2-pyridin-4-ylethyl)-1H-indol-6-yl]benzamide 4-methyl-N-[3-(morpholin-4-yl)phenyl]-3-[3-(piperidin-4-yl)-1,2-benzoxazol-6-yl]benzamide 4-phenoxy-N-(pyridin-2-ylmethyl)benzamide 9-(4-hydroxyphenyl)-2,7-phenanthroline auraptene binimetinib cercosporamide CH5126766 cobimetinib cobimetinib fumarate doramapimod G-573 hypothemycin MK-8353 N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide N-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamide N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydropyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide pamapimod PH 797804 pluripotin RO4927350 SB 203580 SB-202190 SB-239063 SB-245391 SB-284851-BT SB220025 SCH772984 selumetinib TAK-733 talmapimod trametinib trametinib dimethyl sulfoxide U0126 U0126.EtOH VX-745